News|Articles|April 26, 2024
Pharmatech Insights – Business Considerations for Pharmaceutical Continuous Manufacturing
Author(s)Pharmatech Associates
Continuous Manufacturing in pharmaceuticals can increase process understanding while overcoming disadvantages of batch manufacturing: slow and expensive development and tech transfer, plus inefficiencies, product loss, and human error in commercial manufacturing.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
4
How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems
5
